Multiple spider telangiectasias in a breast cancer patient on T-DM1 treatment

被引：4
|
作者：
Ruiz-Rivero, Juncal [1 ,2 ]
Horcajada-Reales, Celia [1 ,2 ]
Tardio, Juan C. [1 ,3 ]
Manuel Borbujo-Martinez, Jesus [1 ,2 ]
机构：
[1] Hosp Univ Sagrat Cor, Barcelona, Spain
[2] Hosp Univ Fuenlabrada, Dept Clin & Surg Dermatol & Venereol, Madrid, Spain
[3] Hosp Univ Fuenlabrada, Dept Pathol Anat, Madrid, Spain
来源：
ANAIS BRASILEIROS DE DERMATOLOGIA | 2018年 / 93卷 / 06期
关键词：
TRASTUZUMAB EMTANSINE;
D O I：
10.1590/abd1806-4841.20187968
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：938 / 939
页数：2
相关论文
共 50 条
  • [21] AT PHASE IB, T-DM1 PLUS NERATINIB IS SAFE AND EFFECTIVE IN BREAST CANCER
    不详
    CANCER DISCOVERY, 2019, 9 (10) : 1339 - 1339
  • [22] Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
    Boyraz, Baris
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Babacan, Taner
    Roach, Emir C.
    Kizilarslanoglu, Muhammet C.
    Petekkaya, Ibrahim
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (04) : 405 - 414
  • [23] Breast cancer brain metastases responding to primary systemic therapy with T-DM1
    Bartsch, Rupert
    Berghoff, Anna S.
    Preusser, Matthias
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (01) : 205 - 206
  • [24] The relationship of the plasma concentration of T-DM1 with PFS and toxicity in breast cancer patients
    Shimomura, Akihiko
    Sumiyoshi-Okuma, Hitomi
    Shimada, Takashi
    Hayashi, Mitsuhiro
    Kitano, Shigehisa
    Yonemori, Kan
    Shimizu, Chikako
    Tamura, Kenji
    Hamada, Akinobu
    CANCER SCIENCE, 2018, 109 : 901 - 901
  • [25] Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients
    Kowalczyk, Lidia
    Bartsch, Rupert
    Singer, Christian F.
    Farr, Alex
    BREAST CARE, 2017, 12 (06) : 401 - 408
  • [26] Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
    Migeotte, A.
    Dufour, V
    van Maanen, A.
    Berliere, M.
    Canon, J. L.
    Taylor, D.
    Duhoux, F. P.
    BMC CANCER, 2021, 21 (01)
  • [27] Trastuzumab emtansine (T-DM1) for HER2-positive advanced breast cancer
    Thibault, C.
    ONCOLOGIE, 2013, 15 (02) : 126 - 127
  • [28] Activity of T-DM1 in HER2-positive breast cancer brain metastases
    Bartsch, Rupert
    Berghoff, Anna S.
    Vogl, Ursula
    Rudas, Margaretha
    Bergen, Elisabeth
    Gnant, Michael
    Dieckmann, Karin
    Pinker, Katja
    Bago-Horvath, Zsuzsanna
    Galid, Arik
    Oehler, Leopold
    Zielinksi, Christoph C.
    Steger, Guenther G.
    Preusser, Matthias
    CANCER RESEARCH, 2015, 75
  • [29] Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
    Duhoux, F. P.
    Dufour, V.
    van Maanen, A.
    Berliere, M.
    Taylor, D.
    Canon, J-L
    CANCER RESEARCH, 2019, 79 (04)
  • [30] Impact of the line of treatment on progression-free survival in patients treated with T-DM1 for metastatic breast cancer
    A. Migeotte
    V. Dufour
    A. van Maanen
    M. Berliere
    J. L. Canon
    D. Taylor
    F. P. Duhoux
    BMC Cancer, 21
12345